Back to search results

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Transitional Cell Cancer of Renal Pelvis and Ureter

Locations
  • University of California - Irvine Medical Center, Irvine, California, United States
  • Keck School of Medicine at USC Medical Center, Los Angeles, California, United States
  • Emory University Hospital, Atlanta, Georgia, United States
  • The Johns Hopkins Hospital, The Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
  • Albany Medical College, Albany, New York, United States
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States
  • The Ohio State University (OSU), Columbus, Ohio, United States
  • The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
  • Medical University of South Carolina (MUSC), Charleston, South Carolina, United States
  • Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
  • University of Texas Southwestern, Dallas, Texas, United States
  • University of Washington, Seattle, Washington, United States
  • CHU de Lille - Hopital Claude Huriez, Lille, France
  • HCL Hopital Edouard Herriot, Lyon, France
  • Universitaetsklinikum Tuebingen, Tübingen, Germany
  • Sheba Medical Center, Ramat Gan, Israel
  • Hospital Universitario de A Coruña, A Coruña, Spain
  • Hospital Universitario Vall d'Hebron, Barcelona, Spain
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)